Cystic Fibrosis-related Diabetes
32
9
12
13
Key Insights
Highlights
Success Rate
76% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.5%
4 terminated out of 32 trials
76.5%
-10.0% vs benchmark
9%
3 trials in Phase 3/4
23%
3 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (32)
Metformin for People With CFRD on CFTR Modulator Therapy to Improve Ion Channel Function
Dorzagliatin in Pancreatic Insufficient Cystic Fibrosis
ACCESS 2: AI for pediatriC diabetiC Eye examS Study 2
Bionic Pancreas in CFRD
Closed-loop for People Living With Cystic Fibrosis Related Diabetes
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Semaglutide in CFRD
SGLT2 Inhibitor Therapy in Cystic Fibrosis-related Diabetes
Comparison of Meal-Time Dosing of Insulin in Cystic Fibrosis Related Diabetes
Continuous Glucose Monitoring and OGTT Screen for Cystic Fibrosis Related Diabetes in Cystic Fibrosis
The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Related Diabetes
CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis
FEED-Cystic Fibrosis (FEED-CF)
Cardiac Structure and Function in Patients with Cystic Fibrosis
Effect of Postprandial Insulin Administration of Faster-acting Insulin Analogue Versus Pre-prandial Administration of Acting-insulin Analogue in Cystic Fibrosis Related Diabetes
Alternate Measures of Glucose During OGTT Testing for CFRD
EnVision CF Multicenter Study of Glucose Tolerance in Cystic Fibrosis
Measurement of Beta Cell Death in Individuals With Cystic Fibrosis
A Pilot Study of a Low Glycemic Load Diet in Adults With Cystic Fibrosis
Feasibility of Outpatient Closed Loop Control With the iLet Bionic Pancreas in Cystic Fibrosis Related Diabetes